"A monumental milestone" in the battle against malaria was set Monday with the rollout of the "R21/Matrix-M" vaccine in the West African nation of the Ivory Coast.
Co-developed by the University of Oxford and the Serum Institute of India, the vaccine is targeted to immunize around 6.6M children in 15 African nations from 2024-25.